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Background: Depressive disorder is a major societal challenge. Despite the availability of clinically and cost-
effective treatments including Internet interventions, the number of patients receiving treatment is limited.
Evidence-based Internet interventions promise wide availability and high efﬁciency of treatments. However,
these interventions oftendo not enter routinemental healthcare delivery at a large scale. TheMasterMindproject
aims to provide insight into the factors that promote or hinder the uptake and implementation of evidence-based
Internet interventions by mental healthcare practice. Internet-based Cognitive Behaviour Therapy (iCBT) and
videoconferencing facilitating collaborative care (ccVC) will be implemented in routine mental healthcare. The
services will be offered to 5230 depressed adults in 15 European regions. The current paper describes the
evaluation protocol for this large-scale implementation project.
Design: Current summative evaluation study follows a naturalistic one-group pretest–posttest design and
assesses three distinct stakeholders: patients, mental healthcare professionals, and mental healthcare organisa-
tions. The Model for Assessment of Telemedicine applications (MAST) will be employed to structure the imple-
mentation and evaluation study. The primary focal points of interest are reach, clinical effect, acceptability,
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appropriateness, implementation costs, and sustainability of the interventions in practice. Mixed-methods are
used to provide an understanding of what (quantitative) the implementation projects have achieved and their
meaning to various stakeholders (qualitative).
Discussion: The use of Internet interventions in routine practice is limited.MasterMind attempts to bridge the gap
between routine practice and effectiveness research by evaluating the implementation of evidence-based Inter-
net interventions for depressive disorders in routine mental healthcare settings in Europe.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Unipolar depressive disorder is currently one of the most prevalent
mental disorders worldwide and is predicted to be the number one
overall cause of disability by 2030 for citizens of higher income
countries (World Health Organization, 2008; Mathers and Loncar,
2006). Depressive disorders can lead to reduced quality of life, impaired
social and personal relationships and disturbed professional life. They
are often accompanied by other psychiatric disorders (e.g. anxiety
disorders, substance abuse) and a variety of physical health problems.
A depressive disorder may start early in life and the course is often
recurrent. (Bijl and Ravelli, 2000; Barney et al., 2006; Titov, 2011).
Therefore, depressive disorders are associatedwith substantial econom-
ic and societal costs, such as cost of treatment, loss of work productivity,
absenteeism, early retirement, and premature death (Ferrari et al.,
2013; Wittchen et al., 2011; Gustavsson et al., 2011).
1.1. Background and rationales
Despite the availability of effective treatments, the number of people
that actually receive treatment for depressive disorders is not optimal.
Care utilization rates for adults with depression range from 35% to 45%
in higher income countries (Andrews et al., 2001; Spijker et al., 2001).
Suggested barriers that contribute to these low rates include, fear of or
perceived stigmatisation (Hengartner et al., 2012; Van Voorhees et al.,
2012), lack of adequately trained therapists, and the costs associated
with healthcare delivery (Kazdin and Blase, 2011; Wittchen et al.,
2011).
eMental health is often regarded as a promising approach in lower-
ing the burden of depressive disorders and entails the use of digital
technologies and new media for the delivery of effective and efﬁcient
mental healthcare. eMental health may contribute to lowering access
barriers to mental healthcare and enable for more efﬁcient use of
healthcare resources through smart Information and Communication
Technology (ICT) solutions (Riper et al., 2010). For example, a large
number of randomized controlled trials and meta-analyses have
demonstrated that Internet-based Cognitive Behavioural Therapy
(iCBT) in comparison with waitlist-control, can be effective in treating
depression. Clinical outcomes are also found to be comparable with
face-to-face interventions when delivered with professional guidance
(Cuijpers et al., 2014, 2008a,b; Cuijpers, 2009; Andrews et al., 2010;
Spek et al., 2007; Ebert et al., 2015b). Additionally, a number of studies
evaluating cost-effectiveness indicate that iCBT might be ﬁnancially
viable for optimising mental healthcare for patients with a depressive
disorder (Warmerdam et al., 2010; Gerhards et al., 2010; Hollinghurst
et al., 2010; Lokkerbol et al., 2014). Despite the evidence showing
clinical effectiveness, limited attention has been paid to potential
negative effects of Internet treatment, such as low self-esteem, therapist
dependency and stigmatisation which desires more research (Rozental
et al., 2014).
Similar to the evidence-base for iCBT, research has also shown that
live videoconferencing technologies can be used to deliver treatments
to patients who are otherwise difﬁcult to reach, and for facilitating
collaboration among healthcare professionals (Shore, 2013; Chung-Do
et al., 2012; Rowe et al., 2008). Although evidence supporting the
effectiveness of videoconferencing in mental healthcare is less rigorous
(García-Lizana and Muñoz-Mayorga, 2010), research has shown that
they can be a viable option for delivering mental healthcare to patients
with mental health problems in both in- and outpatient care settings
(Shore, 2013; Valdagno et al., 2014; Moreno et al., 2012; Chong and
Moreno, 2012; Fortney et al., 2011). Videoconferencing technology inte-
grated in a collaborative settings, such as offeringmultidisciplinary care
to patients through a video-based collaboration of different healthcare
professionals, collaborative care facilitated by videoconferencing
(ccVC) has been shown to be equally effective as or more effective
than practice-based collaborative care for depressed patients (Fortney
et al., 2007).
Examples of successful iCBT and ccVC implementation trajectories
do exist (De Weger et al., 2013; Coulthard et al., 2013). However,
large-scale uptake of eMental health by routine practice is limited
(Brownson et al., 2012; Greenhalgh et al., 2005; Kazdin and Blase,
2011). Suggested factors thatmight hinder the use of Internet interven-
tions include acceptance of iCBT and ccVC in the target population and
of healthcare professionals (Ebert et al., 2015a; Baumeister et al.,
2014), the ﬁnancial reimbursement systems and the availability of ade-
quately trained professionals (Kazdin and Blase, 2011; Emmelkamp
et al., 2013; McHugh and Barlow, 2012).
To strengthen the current knowledge base, our study aims to
evaluate the large-scale implementation of evidence-based eMental
healthcare services for depressive disorders in routine mental
healthcare in Europe with the following two main aims:
1. To investigate the factors that promote or hinder the implementation
of internet-based Cognitive Behaviour Therapy (iCBT) and mental
and collaborative care facilitated by videoconferencing (ccVC) for
treating depressive disorders in routine mental healthcare practice.
2. To investigate the transferability of the identiﬁed factors to different
mental healthcare contexts.
iCBT and ccVC services will be implemented in routine mental
healthcare and offered to at least 5230 depressed adults in 15
European regions. The results will be used to develop guidelines and
recommendations for promoting and facilitating the broader imple-
mentation and up scaling of the evidence-based eMental health services
across Europe.
1.2. Theoretical underpinning
Translating scientiﬁc knowledge into practice is not a new problem,
and is not limited to mental healthcare alone (Rogers, 2003; Brownson
et al., 2012; Greenhalgh et al., 2005). The emergingﬁeld of Implementa-
tion Science might provide guidance in innovating the mental
healthcare practice. Theories such as the Normalization Process Theory
(NPT) developed by May and Finch (May and Finch, 2009), can help to
understandwhy innovations become routine by explaining the process-
es, factors, and work that hinder and facilitate the implementation of
innovations in routine healthcare. For concrete implementation
activities and the evaluation of what they achieved, more pragmatic
frameworks can be used such as the Consolidated Framework for
ImplementationResearch (CFIR) byDamschroder et al. (2009), Glasgow
et al.’s RE-AIM (Glasgow et al., 1999) and the Model for Assessment of
Telemedicine applications (MAST) developed by Kidholm et al.
(2012). These frameworks tend to structure the factors and concepts
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that are relevant for the outcomes of concrete implementation
programmes. Examples of such concepts are the availability of
resources, organisational readiness, the (perceived) usefulness of the
innovation.
In the MasterMind project, the MAST framework is used to both
guide the implementation process aswell as to structure the evaluation.
The MAST framework is based on a broad view and analysis of the
factors and areas to consider and account for when introducing and
implementing telemedicine in an existing healthcare setting. The
MAST assessment tool is a result from the MethoTelemed Study
(Kidholm et al., 2010) and uses the EUnetHTA Core Health Technology
AssessmentModel (EUnetHTA, n.d.) as a starting point. The principal el-
ements of MAST consist of three steps. In the ﬁrst step, a number of pre-
ceding considerations are made regarding legislation, reimbursement
and maturity of the application. This step enables explicit decision-
making regarding the implementation of the targeted innovation. The
second step concerns amultidisciplinary assessment of outcomes across
seven domains, namely: 1. health problem and characteristics of the
intervention, 2. safety, 3. clinical effectiveness, 4. patient and healthcare
professional perspectives, 5. economic, 6. organisational, and 7. socio,
ethical, and legal aspects. This step is designed to take into account
those factors that are found to be relevantwhen implementing complex
interventions in healthcare settings and, as such, sensitizes the further
design of the present evaluation study. The third and ﬁnal step
addresses the transferability and scalability of the implemented services
to other healthcare contexts. In this step, relevant contextual informa-
tion of the outcomes of the multidisciplinary assessment (step 2) will
be provided in order to enable others to determine the applicability of
the ﬁndings to their contexts. Examples are the implementation costs
related to cost-variation per patient, restraints in legislations,
reimbursement systems, et cetera. The current article and subsequent
sections provide a detailed account for executing steps two and three
of the MAST framework in the context of the MasterMind project.
1.3. Objectives
To investigate the factors promoting or hindering implementation of
eMental health in routine care and their transferability to other mental
healthcare contexts, the MAST framework and the seven assessment
domains are translated into six interrelated research questions:
1. To what extent do patients' depressive symptoms improve when
treated with iCBT and ccVC in routine practice? This question relates
to domain 3. Clinical effectiveness of the MAST framework and aims
to provide information on the clinical effects that treatment might
have on patients in real-life routine practice.
2. What costs are associatedwith the implementation and up-scaling of
iCBT and ccVC for treating depression in routine practice? This
question relates to domain 5. Economic aspects, 6. organisational
aspects, and 7. socio, ethical, and legal aspects, of the MAST frame-
work and focuses on real-world investments needed to implement
iCBT and ccVC in routine practice.
3. How is a patient's safety ascertained in terms of their mental health
when provided with iCBT and ccVC operationalized in routine
practice? Information about how the safety of patients is assessed
and managed in practice will inform the implementation and up-
scaling of iCBT and ccVC. This question is related to domain 2. safety
of the MAST framework.
4. To what extent are patients satisﬁed with the iCBT treatment and
ccVC services and the use of technologies for optimising their mental
health? This research question is related to domain 4. patient and
healthcare professional perspectives and will provide knowledge
on howpatients in routine care perceive and value the use of techno-
logical innovations for their treatment.
5. To what extent are healthcare professionals satisﬁed with the iCBT
treatment and ccVC services in terms of their professional needs in
treating patients? Similar to question four, this question will investi-
gate satisfaction and usability of professionals with novel technolo-
gies in providing treatment to their patients. This question will
provide input in domain 4. patient and healthcare professional
perspectives and 6. organisational aspects.
6. How many and what type of patients are reached by the iCBT treat-
ment and ccVC services in routine practice? Finally, knowing what
patients are actually treated with iCBT and ccVC in routine practice
will provide valuable information on the extent to which the inter-
ventions are offered to people with depression who would normally
have no or limited access to treatment. This question is related to do-
main 1. health problem and characteristics of the intervention and
domain 7. socio, ethical and legal aspects of the MAST framework.
In terms of outcomes, the primary outcomemeasure in this study is
implementation effectiveness. Implementation success is deﬁned as a
combination of clinical effectiveness, acceptability and appropriateness,
sustainability, and reach of the interventions implemented in real life
routine practice. The study design, outcomes, measures and instru-
ments are detailed in the following section.
2. Methods and design
2.1. Study design
This study follows a naturalistic summative evaluation of the
implementation of iCBT and ccVC in routine practice. This means that
the primary focus is on the outcomes rather than the process of imple-
mentation. For the current study, the MAST framework is adapted to
cater for items that are speciﬁc for the mental healthcare practice.
Examples of issues that needed to be addressed are the variety of instru-
ments used in practice for estimating symptom severity, referral
modalities, perspectives of healthcare professionals, and the various
interventions applied in MasterMind.
TheMasterMind evaluation assesses multiple levels of stakeholders:
a) patients, b) mental healthcare professionals, and c) mental
healthcare organisations. Mixed-methods are used to provide an
understanding of what (quantitative) the implementation projects
have achieved and the reasons for success or failure (qualitative)
(Gaglio and Glasgow, 2012). The qualitative study is designed to
understand the meaning of the services and implementation efforts to
stakeholders working with the interventions.
The evaluation follows a one-group pretest-posttest design because
iCBT and ccVC are implemented in routine practice with routine care
patients (Campbell and Stanley, 1963). The study connects to routinely
gathered data on, for example, treatment effect where possible. For ex-
ample, the RoutineOutcomeMeasurements (ROM) is usedwhich refers
to a standardised set of instruments used in routine carewith the aim to
systematically and periodically measure the effect of and satisfaction
with the treatment received. By using this existing data source, only a
limited number of questions that require a minimal time investment
from the participants need to be issued. To enable for early learning ef-
fects between the study sites within MasterMind, the implementation
projects are grouped in two separate implementation waves. Wave
one regions are more experienced in providing iCBT to patients and in
using videoconferencing techniques in care settings through e.g. (re-
search) controlled environments or small-scale pilot projects in routine
care. Wave two regions have less experience with iCBT or ccVC and
beneﬁt from sharing knowledge and lessons learned available in the
project. Wave-one regions include Syddanmark (Denmark), Hessen
(Germany), Amsterdam area (The Netherlands), Northern Norway
(Norway) and Scotland (United Kingdom). Wave-two regions include
Veneto and Piemonte (Italy), Tallin area (Estonia), Aragon, Basque
Country, Badalona and Galicia (Spain), Nuuk (Greenland), Ankara
(Turkey) and Wales (United Kingdom).
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2.2. Interventions
2.2.1. Internet-based Cognitive Behavioural Therapy
Within MasterMind, the participating healthcare organisations will
implement evidence-based iCBT interventions in routine mental
healthcare practice. The iCBT interventions are evidence-based in that
there is clinical evidence from randomized controlled trials demonstrat-
ing that the underlying therapeutic principles contribute to improve-
ment of depressive symptoms and health related client outcomes.
Most of the included interventions and underlying technical platforms
have been available on the market for some years. They include inter-
ventions with minimal support (e.g. MoodGym (Christensen et al.,
2002) and Beating the Blues (Proudfoot et al., 2004)), and more recent
developments combining face-to-face with online treatment (Blended
treatment, (Kooistra et al., 2014)) and integrating full video and audio
support (iKAT-D (Hedman et al., 2014) and Get.On Mood Enhancer
(Ebert et al., 2014)). The exact treatment and servicemodalities depend
on the type and structure of the technical iCBT platform, the individual
needs of patients, and the actual care setting. For all implementation
sites, the treatment protocols and technological solutions adhere to
the multidisciplinary NICE clinical guidelines for depression developed
by the National Institute for Care and Excellence in the UK (NICE,
2009). The core components of all iCBT treatments are: (1) psycho-
education, (2) cognitive restructuring, (3) behavioural activation, and
(4) relapse prevention. These components are delivered over a number
of sessions either online (with minimal guidance) or via a combination
of face-to-face sessions with a mental healthcare professional, in alter-
nation with online sessions in which the CBT components are described
and practised. Patients for whom CBT treatment is indicated and who,
for example, have difﬁculty visiting the clinic, will be offered a video
supported iCBT treatment. The online sessionswill be delivered through
a secureweb-based online treatment platform. The platforms are either
owned by a commercial party that licences the implementation sites to
use the service platform or developed by the site themselves. The
Internet platforms include a web-based interface providing patients
with access to iCBT therapy modules, a digital workbook, and a secure
communication channel for both the therapists and the patients.
Additional ﬁle 1 provides an overview of the included iCBT interven-
tions. Staff will be trained in working with the treatment platform
while taking into account their role in treatment delivery (e.g. GP,
referrer, specialist, etc) and can be of a technological nature, therapeutic
nature or both. Training courses are delivered either as part of the
medical training, special training course on cCBT, workshops regarding
written contact, including role-play, presentations, and e-learning
modules to test the skills. On-going support (maintenance) measures
are available and include supervision and intervision, protocols,
manuals and elaborate information packs.
2.2.2. Videoconferencing facilitating mental healthcare and collaborative
care
With mental healthcare and collaborative care facilitated by video-
conferencing (ccVC) we refer to the technical infrastructure, security
measures and the procedures, guidelines, and competences needed to
operate and utilise the videoconferencing technology to the beneﬁt of
treating depressive disorders. Based on the Cochrane deﬁnition of collab-
orative care (Gunn et al., 2006), the videoconferencing services in the
present project are utilised in ﬁve different ways: (a) collaborative care
between specialist and general practitioner (GP), (b) collaborative care
between specialist and GPwith patient, (c) video diagnosis during inclu-
sion to iCBT, (d) follow-up or outpatient care of the patient at home, and
(e) acute care. Videoconferencing will be used with either standard
computer-based (mobile or desktop) videoconferencing devices, or
dedicated and furnished video-conferencing units including a speaking
room with speciﬁc video, audio and connectivity devices. The services
adhere to state of the art communication and security standards for
voice over TCP/IP (Transmission Control Protocol/Internet Protocol).
Scotland, Estonia and Turkey will not deploy ccVC, whereas Greenland
will realize a collaborative care model based exclusively on the use of
videoconferencing. Additionalﬁle 1 provides anoverviewof the included
ccVC services. Depending on their role in providing the services, staff will
be trained in the technical aspects as well as in usability issues and
videoconferencing techniques.
2.3. Population and enrolment
The project will take place in primary care (Italy, The Netherlands,
Norway, Scotland, Wales) and in specialised care (Denmark, Estonia,
Germany, Greenland, Italy, The Netherlands, Spain, Turkey). In each
setting participants at the level of the (1) patient, (2) healthcare profes-
sional, and (3) mental healthcare organisation will be recruited. Table 1
provides the target number of participants for each of the participating
implementation sites. The target numbers are based on purposive quota
sampling meaning the number of participants needed to be enrolled to
be able to regard the interventions as being implemented in routine
practice when the study is ﬁnished. With estimating the sample sizes,
feasibility and regional service delivery characteristics are taken into
account.
2.3.1. Patients' enrolment
Consecutive adult patients (N = 5230) from routine mental
healthcare practice will be offered iCBT or ccVC or both, and will be
invited to participate in the study when they have symptoms of mild,
moderate or severe depression. The symptoms will be established in
accordance with routine working procedures at the participating
implementation sites.
At the time of enrolment, patients will be classiﬁed in three
categories: (1) patients who want to receive iCBT, (2) those that want
to receive iCBT, and perform Routine Outcome Measurements (ROM)
or similar, and (3) those that want to receive iCBT, perform ROM and
agree to ﬁll out additional questionnaires. These three categories are
reﬂected in the ﬂow diagram presented in Fig. 1. The additional
questionnaires aim to capture patient's perspectives regarding satisfac-
tion with and usability of the intervention.
2.3.2. Enrolment of healthcare professionals
Healthcare professionals (N= 141) are included in the study if they
provide patients with iCBT treatment, refer patients to the iCBT service
included in study, or are clinically involved in treating depressed
patients by making use of the ccVC service. As such, healthcare
Table 1
Overview of the number of patients, healthcare professionals and organisations to be
included.
Patients Healthcare
professionals
Organisations
Syddanmark (DK) 800 16 23
Scotland (UK) 800 16 1
Wales (UK) 500 10 9
GGZ InGeest Amsterdam Area (NL) 300 6 4
Aragon (ES) 100 2 1
Basque Country (ES) 300 6 3
Badalona Serv. Assist. (ES) 200 4 1
Galicia (ES) 200 4 1
Veneto (IT) 200 20 1
Piemonte (IT) 300 6 1
Turkey (TR) 200 3 1
Hessen (DE) 500 10 1
North. Norway (NO) 500 30 16
Estonia (EE) 300 6 1
Greenland (GL) 30 2 1
Total 5230 141 65
The number of patients to be included is based on quota sampling. The number of
healthcare professionals and mental healthcare organisations follows from the number
of patients that can be treated in routine care.
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professionals in the study can be therapists, team leaders and referrers,
and vary from General Practitioners to psychiatrists and psychologists.
This broad deﬁnition allows for assessing the transferability of the
ﬁndings in different healthcare settings. The recruited healthcare
professionals have received clinical iCBT and ccVC training.
2.3.3. Enrolment of mental healthcare organisations
Mental healthcare organisations (N= 65) are deﬁned as the service
providers that implement the iCBT interventions and/or ccVC services in
their routinepractice. The organisations involved vary fromGPpractices
to large specialised care centres. For each involved healthcare provider,
a representative will be invited to take part in the study. To be included
in the study, the representative should have substantive decision-
making power related to the management of their organisation's
mental healthcare practice.
2.4. Outcomes and measurements
Implementation outcomes are deﬁned as the effects of deliberate
and purposive actions to implement new treatments, practices, and
services (Proctor et al., 2011). The primary outcome measure in this
study is implementation success. Following the research questions, im-
plementation success is deﬁned as a combination of reach, clinical
effectiveness, acceptability and appropriateness, implementation costs,
and sustainability (Proctor et al., 2011). Following the RE-AIM frame-
work (Glasgow, 2007), reach is deﬁned as the participation rate and
representativeness of patients at an individual level and provides
valuable insight into the uptake of iCBT and ccVC in real world settings.
Clinical effectiveness is deﬁned in MasterMind to be clinical improve-
ment of depressive symptoms according to routine practice. Acceptabil-
ity refers to the perception among stakeholders that the treatment is
satisfactory. Appropriateness relates to the perceived ﬁt in addressing
the mental disorder (Proctor et al., 2011). The actual cost for
implementing the intervention will be estimated in terms of both the
investment and recurrent costs (direct and indirect) a healthcare orga-
nisation bears when implementing iCBT and/or ccVC. Sustainability is
the extent to which the intervention in routine practice is maintained
(Proctor et al., 2011).
Although purposive sampling for patients and healthcare profes-
sionals is applied, we do not set forth a speciﬁc deﬁnition of implemen-
tation success in terms of the number of patients treated or therapists
recruited. In that sense the sites that have obtained the quota are as in-
teresting to this study as those who do not reach the number of patients
we currently envisage the site should be able to treat (based on previous
experiences, reach of routine healthcare services, etc.). Rather, we aim
to identify the differences between sites that do and those that do not
meet their quota and to elucidate the possible factors contributing to
those differences.
Table 2 provides an overview of the research questions in relation to
theMASTdomains and the instruments thatwill be used tomeasure the
operationalized indicators. The indicators and items are rooted in
existing literature in Implementation Science, notably the Consolidated
Framework for Implementation Research (Damschroder et al., 2009),
the Conceptual model of Implementation Research (Proctor et al.,
2009), and the Determinants of Innovations (MIDI) developed by
Fleuren et al. (2010, 2014).
2.4.1. Patient-level outcomes
Patient level outcomes are reach, acceptability and appropriateness
of the treatment in alleviating depressive symptoms. Reach will be
calculated by dividing the number of patients that received iCBT and/
or were treated by using ccVC, by the number of people in the general
population that would normally receive treatment for depression.
These numbers will be estimated on the basis of existing epidemiologi-
cal data available from e.g. World Health Organization (WHO) and
Eurostat, and regional/national statistics. Acceptability is the perception
among patients that the received treatment is agreeable, palatable, or
satisfactory (Proctor et al., 2011) and includes the safety of the
Fig. 1. Enrolment of participants. Adult patients with depression in routine care will be offered iCBT and/or ccVC and invited to take part in the study.
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treatment. Appropriateness is the perceived ﬁt, relevance, or compati-
bility of the treatment for the patient in addressing his or her mental
disorder (Proctor et al., 2011). Acceptability and appropriateness will
be measured through (a) establishing improvement in depressive
symptoms and quality of life, (b) establishing perceived satisfaction
with the treatment, (c) establishing the perceived usability of the treat-
ment and (d) treatment attrition. The method for measuring the
symptoms of depression will adhere to routine practice and will be
registered in terms of: clinical interview, professional clinical judge-
ment, or a symptom questionnaire. Symptoms are recorded in terms
of no, mild, moderate, severe, and very severe symptoms according to
routine practice diagnostic procedures. Quality of life will be measured
using an adapted version of theManchester Short Assessment of Quality
of Life (MANSA) (Priebe et al., 1999). The questionnaire consists of two
questions about patients' satisfaction with their health in general and
their mental health speciﬁcally. The MANSA showed satisfactory
psychometric properties (Björkman and Svensson, 2005). Patient
Satisfaction will be measured with the 8 items Client Satisfaction
Questionnaire (CSQ-8) (Larsen et al., 1979). The CSQ-8 is a Likert scale
with 8 items and is a very brief instrument to investigate client satisfac-
tion with the delivered services. It has good psychometric properties,
and it has been tested in numerous studies on diverse client samples
(Attkisson and Zwick, 1982). Usability will be measured with the Sys-
tem Usability Scale (SUS) (Brooke, 1996). The SUS is a 10-item Likert
scale and a brief instrument to measure perceived system usability. It
is proven to have good psychometric properties (Brooke, 2013; Lewis
and Sauro, 2009). Attrition is the phenomenon of participants stopping
to use the treatment and/or being lost to post-treatment assessment
(Eysenbach, 2005). Attrition will be measured by dropout rates in
relation to the number of online therapeutic sessions ended successful-
ly. Where possible, reasons for dropout will be included as well.
2.4.2. Healthcare professional-level outcomes
Healthcare professional level outcomes are acceptability and appro-
priateness of the interventions in terms of a) perceived satisfactionwith
the intervention, and b) perceived usability of the treatment in their
daily work. Satisfaction will be measured with the 3 items Client
Satisfaction Questionnaire (CSQ-3) (Larsen et al., 1979) (see above).
Usability will be measured with the System Usability Scale (SUS)
(Brooke, 1996) (see above). Additionally, speciﬁc focus group
discussions will be held with involved healthcare professionals on the
following topics:
- Safety issues related to using the iCBT and ccVC services.
- Reasons for dropout of patients from the intervention.
- Organisational aspects such as leadership engagement, implementa-
tion strategies, and perceived innovation climate within the organi-
sation (resources, rewards, and self-efﬁcacy, etc.) and within the
healthcare profession (knowledge, beliefs, attitude, ﬁt, etc.) in
innovating the daily mental healthcare practice.
- Socio, ethical and legal aspects such as the use of clinical guidelines
and professional liability.
2.4.3. Organisation-level outcomes
The organisation level outcomes are implementation costs and
sustainability of the intervention in routine care. Implementation costs
are deﬁned as the cost impact of an implementation effort (Proctor
Table 2
Overview of the research questions in relation to the MAST domains and the instruments that will be used for measuring the operationalized indicators.
Research question MAST domain Instrument
1. To what extent do patients' depressive symptoms improve when treated with
iCBT and ccVC in routine practice?
3. Clinical effectiveness
ROMa; treatment platform; MANSAb
questionnaire
2. What costs are associated with implementing and up-scaling of iCBT and ccVC
for treating depression in routine practice?
5. Economic aspects;
6. Organisational aspects.
Questionnaire; semi-structured
interview
3. How is the patients' safety in terms of their mental health when provided
with iCBT and ccVC operationalized in routine practice?
2. Safety; 3. Clinical effectiveness ROM; technical platform; questionnaire
4. To what extent are patients satisﬁed with the iCBT treatment and ccVC
services and do they ﬁnd the interventions usable in relation to their needs? 4. Patient and healthcare professional
perspectives; 6. Organisational aspects; 7. Socio,
ethical and legal aspects.
For satisfaction: CSQ-8c (patient) and
CSQ-3c (healthcare professional); For
usability: SUSd
5. To what extent are healthcare professionals satisﬁed with the iCBT treatment
and ccVC services and do they ﬁnd the interventions usable in terms of their
professional needs?
6. How many and what sort of patients are reached by the iCBT treatment and
ccVC services in routine practice?
1. Health problem and general characteristics.
ROMa; treatment platform;
questionnaire.
a ROM stands for Routine OutcomeMeasurements and refers to a standardised set of instruments used in routine carewith the aim to systematically and periodicallymeasure the effect
of and satisfaction with the treatment received.
b MANSA stands for theManchester Short Assessment of Quality of Life used to measure quality of life.
c CSQ is the abbreviation for Client Satisfaction Questionnaire used to measure satisfaction with the services.
d SUS stands for the System Usability Scale and is used for measuring the perceived usability of the services.
Table 3
Patient level measurements.
Dimension Instrument Time burden Base line End of treatment End of study
Demographics Patient ROMa ±15 min depending on routine practice X
Patient safety ROMa X (+ROMa) X
Depressive symptoms ROMa X (+ROMa) X
Quality of life MANSAb 1 min X (+ROMa) X
Treatment access Questionnaire 1 min X
Drop-out Technical platform/questionnaire 2 min X X
Patient perceived satisfaction CSQ-8c 3 min X
Patient perceived usability SUSd 3 min X
a ROM stands for Routine OutcomeMeasurements and refers to a standardised set of instruments used in routine carewith the aim to systematically and periodicallymeasure the effect
of and satisfaction with the treatment received.
b MANSA stands for theManchester Short Assessment of Quality of Life used to measure quality of life.
c CSQ is the abbreviation for Client Satisfaction Questionnaire used to measure satisfaction with the services. The items are adapted to the speciﬁc context.
d SUS stands for the System Usability Scale and is used for measuring the perceived usability of the services. The items are adapted to the speciﬁc context.
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et al., 2011). The implementation costs will be assessed by two means.
First the representatives of the healthcare organisations involved will
be asked to provide actual information on the costs related to
implementing the services Secondly, the issue of implementation
costs will be discussed as a theme in the semi-structured interviews
with the representatives of the healthcare organisations. The items for
the questionnaires and semi-structured interviews assessing imple-
mentation costs are informed by relevant indicators put forward by
e.g. Fleuren et al. (Fleuren et al., 2014) and the Consolidated Framework
for Implementation Research (CFIR) by Damschroder et al. (2009) and
include items on therapist treatment time, caseload, consultation
rates, incidental expenditures for e.g. support staff, training, and mate-
rials, and recurrent operational costs (direct and indirect) for sustaining
the services in routine care. The interviews will include items mecha-
nisms (i.e. business cases, strategies, etc.) for ﬁnancing incidental
(implementation) costs and ﬁnancing a sustainable use of the services
in their practices. Both the questionnaire and the semi-structured
interviews will take place at t = end of study (i.e. at the end of the
inclusion period).
Maintenance concerns the extent to which the implemented
treatment is maintained or institutionalized within a mental healthcare
organisation's on-going, stable operations. Maintenance involves
longer-term effects and is associatedwith organisation's funding strate-
gies (Proctor et al., 2011).Maintenancewill bemeasured in terms of the
intended sustained use of the intervention by the organisation. Both
implementation costs and the intended maintenance of the interven-
tion in routine practice will be measured through semi-interviews
with representatives of the involved mental healthcare organisations
covering issues such as perceived success of implementation projects
and the presence (or absence) of speciﬁc funding strategies for sustain-
ing the intervention in daily practice.
2.4.4. Measurements
Patients enter the study at time point t=0 and start their treatment.
Treatment ends at time point t = end which depends on the speciﬁc
treatment modalities in a study site, e.g. after the relapse prevention
module. Patients receive a questionnaire at the start of their treatment
either through their therapist, referrer or treatment platform. This ques-
tionnaire is MasterMind speciﬁc. Time points for in-between measure-
ments follow routine monitoring modalities (e.g. ROM) in a speciﬁc
study site. Patients receive an online closure questionnaire directly
after their treatment ends including when they prematurely end the
treatment (drop-out). This questionnaire is designed speciﬁcally for
MasterMind. Healthcare professionals are invited for the focus-group
discussions at the end of the study, i.e. when their last patient has
been included and started the treatment. A preparing questionnaire is
included in the invitation for the healthcare professionals. The semi-
structured interviews with the representatives of the healthcare
organisations are also scheduled at the end of the inclusion period and
also they receive a questionnaire to prepare the interviews. Tables 3-5
provide an overview of the measures and their time of assessment.
All questionnaire measures, focus group discussions and interviews
will be conducted in local language. When no translation is available,
local implementation teams will translate the questionnaire by the
forwards-backwards method. Questionnaires will be issued online.
The focus-group interviews with the healthcare professionals will be
held in a face-to-face setting. The structured interviews with the
representative of the participating mental healthcare providers will be
conducted either face-to-face or by telephone. Preceding the focus-
group interviews and structured interviews, participants will be asked
to ﬁll out a short questionnaire to obtain general information about
the interviewees and to prepare them for the interviews. Local inter-
viewers and focus group leaders will be trained and provided with
Table 4
Healthcare professional level measurements.
Dimension Instrument Time Burdon Base line End of treatment End of study
Demographics Healthcare professional Questionnaire 3 min X
Professional experience Questionnaire X
Healthcare professional case load Questionnaire 2 min X X
Healthcare professional perceived satisfaction CSQ-3a 1 min X
Healthcare professional perceived usability SUSb 3 min X
Perceived patient safety by healthcare professional Focus-group interview Maximum 60 min X
Perspective on drop-out Focus-group interview X
Leadership engagement (commitment) Focus-group interview X
Resources (time) Focus-group interview X
Knowledge and beliefs about intervention Focus-group interview X
Self efﬁcacy Focus-group interview X
State of change Focus-group interview X
Identiﬁcation with organisation Focus-group interview X
Support Focus-group interview X
Rewards Focus-group interview X
Priority Focus-group interview X
Professional liability Focus-group interview X
a CSQ is the abbreviation for Client Satisfaction Questionnaire used to measure satisfaction with the services. The items are adapted to the speciﬁc context.
b SUS stands for the System Usability Scale and is used for measuring the perceived usability of the services. The items are adapted to the speciﬁc context.
Table 5
Organisational level measurements.
Dimension Instrument Time Burdon Base line End of treatment End of study
Implementation costs Questionnaire Maximum 10 min X
Operational costs Questionnaire X
Demographics organisation Questionnaire X
Maintenance Structured interview X
Implementation strategy Structured interview Maximum 30 min X
Perspective on implementation Structured interview X
Guidelines Structured interview X
Public image/benchmarking Structured interview X
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elaborate interview guides including tips for interview techniques as
well as elaborate questions.
2.4.5. Triangulation
Credibility and validity will be ensured through cross veriﬁcation
(i.e. triangulation) of the outcomes of the various methods. This takes
place in three ways:
a) Within healthcare professionals— therapists/referrers: conﬁrmative
research of the CSQ-3 and SUS questionnaires that are administered
to healthcare professionals
b) Within healthcare professionals — team leaders: conﬁrmative
research of the CSQ-3 and SUS questionnaires that are administered
to healthcare professionals
c) Between healthcare professionals and healthcare organisations —
upper-level management: conﬁrmative research of the focus groups
with professionals and team leaders.
2.5. Analyses
The analyses will include both quantitative and qualitative data
observed before and after the implementation of cCBT and ccVC in
routine practice. Datawill be analysed per local study site and combined
to study and compare the outcomes on an aggregated level. Because all
study sites implement comparable interventions (i.e. iCBT and ccVC),
the quantitative data collected across all MAST domains will be
combined and synthesised inline with the standards for Comparative
Effectiveness Reviews (CER) and Individual Patient Data meta-analysis
(IPDMA). Where relevant, any assumptions underlying analyses will
be detailed and reported.
2.5.1. Analyses at the level of patients
Descriptive statistics will be used to analyse all study outcomes.
Appropriate GLMmodelswill be used to compare clinical improvement,
perceived sustainability and usability of the services, across implemen-
tation sites, with terms for services (interventions) and implementation
sites, reported as odds ratioswith 95% conﬁdence intervals (CI).Within-
group and sub-group comparisons will be performed and an effect size
Cohen's d will be calculated to determine the size of the clinical im-
provement. Heterogeneity between sites will be determined by ﬁtting
ﬁxed interaction terms between services and implementation sites,
while overall service effect will be reported with implementation site
treated as a ﬁxed effect and time treated as a random effect. Sensitivity
analyses will be conducted adjusting for important baseline covariates.
To be able to come to a comprehensive summative evaluation of the
implementation projects, missing data, due to for example dropout is
important information in the interpretation of client satisfaction and
usability. Hence, no imputation techniques will be applied. Participants
that prematurely dropout of treatment and/or the study, will be
requested to provide the healthcare professionals with information
about the reasons for dropout and the issue of dropout will be included
as a theme in the focus-group discussions with the healthcare
professionals.
2.5.2. Analyses at the level of healthcare professionals
Analysis of the perceived satisfaction and usability of the iCBT and
ccVC services by the healthcare professional follows the sameprocedure
as patient level analyses. For the data collection and analysis of qualita-
tive data, both inductive and deductive methods will be applied. The
qualitative evaluation aligns to a constructivist understanding of the
factors that facilitate or hinder implementation as the focus is on the
meanings that groups of healthcare professionals and individuals on
managerial positions hold towards implementing cCBT and ccVC.
Building on existing work such as the Consolidated Framework
for Implementation Research (CFIR) (Damschroder et al., 2009),
Measurements for Determining Innovation (MIDI), (Fleuren et al.,
2014), RE-AIM (Glasgow et al., 1999) and the Normalisation Process
Theory (NPT) (May and Finch, 2009) the initial themes within the
MAST domains are identiﬁed. Saturation of themes will be achieved in-
ductively in a pilot study and purposive sampling will be applied to ob-
tain data saturation. For each theme, a combination of a predetermined
set of replies and open-answering approach will be applied. Thematic
analysis will be used to analyse the qualitative data from the focus
groupdiscussions. Semantic units ofmeaning related to the study objec-
tiveswill be identiﬁed inductively within the qualitative data and coded
and included in the overall analysis (Braun and Clarke, 2006). Analysis
on combined data will be of a descriptive nature rather than to average
out the heterogeneity between levels and contexts of sites. This will be
done by narrative summaries in the form of simple descriptions and
tables of disaggregated data (Dixon-Woods et al., 2005).
2.5.3. Analyses at the level of mental healthcare organisations
Descriptive statistics will be used to analyse the data on implemen-
tation costs. The qualitative data obtained by the semi-structured inter-
views with the representatives of the mental healthcare organisations
will be analysed in the same way as the data from the healthcare
professionals.
3. Study status
All ﬁrst wave implementation sites have presented the study
protocol to relevant medical ethical committees and relating regulatory
agencies. Independently from each other, the committees have decided
to exempt the local trials from further scrutiny to ethical regulations for
medical or social research. The committees concluded that this study is
to be regarded as implementing evidence-based interventions and no
human or animal experiments are involved. Second wave implementa-
tion sites are in the process of obtaining approval or exempt from
relevant medical ethical committees. First wave implementation sites
started to enrol patients from the 1st of January 2015. Secondwave im-
plementation sites expect to start enrolling theﬁrst patients in the study
at 1st of October 2015. Enrolment for both wave 1 and wave 2 sites will
end in December 31st of 2016. Analyses will be ﬁnalised in February
2017 and reporting follows subsequently.
4. Discussion
Depression has a large impact on people and society. However, de-
spite the growing emphasis on applying evidence-based interventions
in treating depression, limited progress has been made with respect to
reducing the actual burden of depression in routine practice. Therefore,
the aim of the current study is to implement at scale evidence-based
treatment for depression and to learn from this.
4.1. Strengths and limitations
Routine practice is MasterMind's laboratory, and one of the
strengths of the present study lies in the attempt to capture the hetero-
geneity of the target population on all three levels: patients, healthcare
professionals and mental healthcare organisations and within a variety
of European mental healthcare systems. Through in-depth mixed-
methods a rich picture of the processes and impact of implementation
and sustainability in different contexts will be provided. By doing so
formultiple levels and systems,wemight be able to shed light on the in-
teractive environment in which different stakeholders operate in daily
life while attempting to implement innovative clinical services. For ex-
ample, a better understanding of the way the innovation culture in an
organisation and within the healthcare profession can promote or in-
hibit the uptake of evidence-based interventions by individual thera-
pists might be helpful in developing more successful implementation
strategies. Knowing towhat extend iCBT and ccVC services are palatable
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to healthcare professionals and ﬁt within their daily activities, will
enable us to more effectively and efﬁciently innovate practice to the
ultimate beneﬁt of the patient.
It should be noted that the MasterMind study is active against the
backdrop of the current state of the theoretical underpinning of psycho-
logical interventions through the Internet (Ritterband et al., 2009; De
Los Reyes and Kazdin, 2006). Advancements in the current understand-
ing of working mechanisms in Internet interventions will enable more
targeted adaptations of interventions to their context, which might
also lead to higher adoption and implementation rates.
Having two interrelated implementationswaves is a strong aspect of
the present study as this enables studying thedifferences between orga-
nisations with more and those with less experience in using iCBT and
ccVC in practice and the impact on the implementation outcomes.
Another strength of this study is that the measurements for
obtaining data for the evaluation are designed to have the lowest
possible burden on participants. It is important that implementation
research does not interfere with the process of implementing a new
service because this might lead to a distorted picture of reality
(Proctor et al., 2009). However, this immediately poses some limitations
on the study, as the datamight not be sufﬁcient to explain causalitywith
absolute certainty. We do not set out to answer a speciﬁc hypothesis.
The evaluation aligns to a constructivist understanding of the factors
that facilitate or hinder the implementation and up-scaling of cCBT
and ccVC in routine care practice. Consequently, the present study is
limited in being decisive in determining the clinical or cost-
effectiveness of the treatments.
Rather, MasterMind attempts to bridge the apparent gap between
routine practice and effectiveness research by providing knowledge of
the factors involved in implementing Internet interventions in routine
care so to maximise the intended beneﬁts of evidence-based eMental
health. This knowledge needs to be speciﬁc and informative to themen-
tal healthcare context in which the innovation is to be implemented so
it can to support policy and decision-making to develop speciﬁc imple-
mentation strategies describing the planned effort and tools to perform
the work that is needed to implement innovations in routine care in an
effective and efﬁcient manner.
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